Company Active LTD

Company profile

Emteq Limited

emteq labs | Measure what matters

Real-time emotion sensing & analytics technology - Emteq.

CRN
09708880
Founded
2015
Age
10

Overview

Legal name
EMTEQ LIMITED
Region
South East England
Registered address
SUSSEX INNOVATION CENTRE
SCIENCE PARK SQUARE
BRIGHTON
UNITED KINGDOM
BN1 9SB
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Emteq Limited
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

8 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

01 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

17 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Nov
2024

Mortgage Satisfy Charge Full

Mortgage

MR04 | Transaction MzQ0NDc1MDIwMmFkaXF6a2N4

Published 25 Nov 2024 10:39

16 Oct
2024

Accounts With Accounts Type Total Exemption Full

Accounts Awaiting analysis

AA | Transaction MzQzOTgyMTUzMGFkaXF6a2N4

Published 16 Oct 2024 11:35

07 Oct
2024

Mortgage Create With Deed With Charge Number Charge Creation Date

Mortgage

MR01 | Transaction MzQzODU2NTQ4M2FkaXF6a2N4

Published 09 Oct 2024 01:36

29 Jul
2015

Incorporated

Inception

Company registered at Companies House

Public funding

13 awards
First funded
2015
Funded years
2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022
Age at first award
0 years

Projects

2022 Feasibility Studies Lead participant

Annotating Recorded Telemetry for Extracting Meaning and Insight from Scenarios in Virtual Reality (ARTEMIS-VR)

1 Jan 2022 to 31 Mar 2022

Awarded
£26,763
Total cost £38,233

Producers of screen fiction face a daunting challenge in capturing the attention of audiences. The current gold standard used by industry CEOs and film content producers to understanding if a film or TV pilot will be commercially viable is audience testing. The structure of audience testing has changed little since it was first used in 1928\. A target aud...

2021 CR&D Bilateral Lead participant

Virtual Reality rehabilitation tailored to older brain injury patients

1 Apr 2021 to 30 Sep 2022

Awarded
£396,278
Total cost £566,112

As EU populations age, their risk of disease that impacts brain function leading to difficulties in everyday life and care requirements increases. Dementia (10M EU sufferers projected to double by 2030) and stroke (1.1M EU events each year) affect older members of society and significantly impact the individual who may then need additional help rehabilita...

2020 EU-Funded Lead participant

PSYCH-AID

1 Oct 2020 to 30 Sep 2023

Awarded
£310,397
Total cost £536,731

Awaiting Public Project Summary

2020 Innovation Loans Lead participant

Improving Mental health therapy Provision, Research & Outcomes via Virtual Environments (IMPROVE)

14 Aug 2020 to 14 Feb 2022

Awarded
£900,000
Total cost £937,833

One in six UK adults are affected by a mental health disorder (ranging from phobias to psychosis), but most do not receive treatment (NHS Digital 2016). People who do receive treatment are more likely to be given general medication rather than a targeted and personalised psychological intervention. Yet, for many common mental health conditions, particular...

2020 Feasibility Studies Lead participant

Project continuity grant for digital health innovations addressing remote monitoring and therapy for mental health & chronic neurological conditions

1 Jun 2020 to 30 Nov 2020

Awarded
£250,000
Total cost £250,000

no public description

2020 Feasibility Studies Lead participant

Front Line Access to Multi-sensory E-PTSD (FLAME) Digital Therapies to improve mental health

1 Jun 2020 to 30 Nov 2020

Awarded
£49,288
Total cost £49,288

There is a high emotional cost of treating multiple severely ill patients, triaging those to save, whilst working under severe resource constraints. Health care workers are engaged in a prolonged battle against a deadly, highly contagious illness with no known cure. Following the 2003 SARS outbreak, many health care workers reported high levels of stress,...

2020 Collaborative R&D Lead participant

SMART Augmented Reality platform for increasing the mobility and independence of Parkinson’s disease patients – SMARTAR

1 Jan 2020 to 30 Jun 2021

Awarded
£346,826
Total cost £495,466

Parkinson's disease is a progressive neurological condition that affects over 6 million people worldwide. Half of Parkinson patients suffer from a condition called Freezing of Gait, where they feel as if their feet are "glued" to the ground. This sensation can occur when you start to walk or while walking and many last for several seconds to minutes. In t...

2019 Collaborative R&D Lead participant

Mobile Observation Of Depression (MOOD) platform for digital phenotyping

1 Jun 2019 to 31 Dec 2022

Awarded
£540,995
Total cost £1,081,990

"Emteq Ltd, based at the Sussex Innovation Centre, is developing a wearable digital platform that allows real-time objective monitoring of novel markers of depression. The World Health Organization (WHO) estimates more than 300m people are living with depression. In the UK, up to 10% of people will suffer from depression at some point in their lives; acco...

2019 Feasibility Studies Lead participant

ALERT- Adaptive Learning Eyeware & Remote Tracking version 2.0

1 Jan 2019 to 31 Dec 2019

Awarded
£171,240
Total cost £244,629

Fatigue causes reduced mental or physical performance. It can be caused by sleep loss, extended wakefulness, 'body clock' mismatch (jetlag) or workload. It can lead to errors, sometimes with grave consequences. Workers operating in safety-critical environments, such as pilots, air traffic controllers, and surgeons, have strictly enforced rules governing w...

2018 Feasibility Studies Lead participant

Emotion sensing for improved content creation and personalised immersive experiences

1 Dec 2018 to 31 Mar 2019

Awarded
£31,097
Total cost £44,425

"Communication platforms have transitioned from a one-to-many structure (broadcast media) to a one to one interaction. This increasing personalisation means that ever more content is needed to match the growing number of demographic niches. In 2016, sales of VR headsets were below original market forecasts. The total number of units (not including their s...

2017 Collaborative R&D Lead participant

SEEM: Sensor-Enabled Emotion Monitoring Eyewear

1 Nov 2017 to 30 Apr 2019

Awarded
£100,326
Total cost £143,323

Parkinson's Disease affects 30 million people worldwide (Frederico et al 2012) and is the second commonest neurodegenerative disorder. Symptoms include tremors, loss of facial expressivity, loss of vocal projection, muscle rigidity, dropping posture, walking difficulty. There are 10,000 new cases of Parkinson’s disease (PD) each year in the UK. One reason...

2016 Feasibility Studies Lead participant

Feasibility of emotion detection via facial muscle activity sensors embedded in glasses frame - FEDEm-Glasses

1 Dec 2016 to 31 May 2017

Awarded
£31,715
Total cost £50,000

We have developed novel, miniaturised muscle activity sensors that work without the need for invasive procedures. We aim to integrate these into a glasses frame. In combination with a six-axis motion sensor (gyroscope and accelerometer) we want to demonstrate: -Detection of corrugator (frown) muscle activity, without drawbacks of EMG (skin preparation, ob...

Product types

Collaborative R&D CR&D Bilateral EU-Funded Feasibility Studies GRD Proof of Concept Innovation Loans